Shenzhen YHLO Biotech Co., Ltd. (688575.SS)
CNY 16.47
(0.37%)
CNY 16.47
(0.37%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 989.55 Million CNY | -53.94% |
| 2022 | 2.14 Billion CNY | 220.84% |
| 2021 | 669.56 Million CNY | 11.4% |
| 2020 | 601.05 Million CNY | 35.16% |
| 2019 | 444.68 Million CNY | 54.16% |
| 2018 | 288.45 Million CNY | 48.56% |
| 2017 | 194.15 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 275.26 Million CNY | 3.0% |
| 2024 Q1 | 267.23 Million CNY | -8.76% |
| 2024 Q3 | 289.97 Million CNY | 5.35% |
| 2023 Q2 | 237.79 Million CNY | -18.71% |
| 2023 FY | 989.55 Million CNY | -53.94% |
| 2023 Q3 | 294.2 Million CNY | 23.72% |
| 2023 Q1 | 292.51 Million CNY | -23.99% |
| 2023 Q4 | 292.87 Million CNY | -0.45% |
| 2022 Q2 | 431.51 Million CNY | -51.05% |
| 2022 FY | 2.14 Billion CNY | 220.84% |
| 2022 Q4 | 384.85 Million CNY | -14.55% |
| 2022 Q1 | 881.46 Million CNY | 379.08% |
| 2022 Q3 | 450.38 Million CNY | 4.37% |
| 2021 Q1 | 133.02 Million CNY | -30.25% |
| 2021 FY | 669.56 Million CNY | 11.4% |
| 2021 Q4 | 183.99 Million CNY | 0.81% |
| 2021 Q2 | 170.03 Million CNY | 27.82% |
| 2021 Q3 | 182.5 Million CNY | 7.34% |
| 2020 Q2 | 200.58 Million CNY | 197.98% |
| 2020 Q4 | 190.72 Million CNY | 33.91% |
| 2020 FY | 601.05 Million CNY | 35.16% |
| 2020 Q3 | 142.42 Million CNY | -28.99% |
| 2020 Q1 | 67.31 Million CNY | 0.0% |
| 2019 FY | 444.68 Million CNY | 54.16% |
| 2018 FY | 288.45 Million CNY | 48.56% |
| 2017 FY | 194.15 Million CNY | 0.0% |